摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-(N-methoxy-N-methylcarbamoyl)-5-phenyloxazolidine | 163625-41-0

中文名称
——
中文别名
——
英文名称
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-(N-methoxy-N-methylcarbamoyl)-5-phenyloxazolidine
英文别名
tert-butyl (4S,5R)-4-[methoxy(methyl)carbamoyl]-2,2-dimethyl-5-phenyl-1,3-oxazolidine-3-carboxylate
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-(N-methoxy-N-methylcarbamoyl)-5-phenyloxazolidine化学式
CAS
163625-41-0
化学式
C19H28N2O5
mdl
——
分子量
364.442
InChiKey
URNUVSHZKMUJCE-LSDHHAIUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    448.7±55.0 °C(Predicted)
  • 密度:
    1.131±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    68.3
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-(N-methoxy-N-methylcarbamoyl)-5-phenyloxazolidine 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 反应 0.33h, 以91%的产率得到(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-formyl-5-phenyloxazolidine
    参考文献:
    名称:
    Gold(I)-Catalyzed Asymmetric Aldol Reaction of N-Methoxy-N-methyl-.alpha.-isocyanoacetamide (.alpha.-Isocyano Weinreb Amide). An Efficient Synthesis of Optically Active .beta.-Hydroxy .alpha.-Amino Aldehydes and Ketones
    摘要:
    Asymmetric aldol reaction of N-methoxy-N-methyl-alpha-isocyanoacetamide (alpha-isocyano Weinreb amide) with aldehydes [RCHO: R = Ph, Me, i-Pr, (E)-MeCH=CH, (E)-BnOCH(2)CH=CH] in the presence of a gold(I) catalyst prepared in situ from [Au(c-HexNC)(2)]BF4 and chiral ferrocenylphosphine ligand (R)-N-methyl-N-(2-morpholinoethyl)-1-[(S)-1',2-bis(diphenylphosphino)ferrocenyl]ethylamine gave high yields of optically active trans-5-alkyl-2-oxazoline-4-(N-methoxy-N-methylcarboxamides) with high diastereo- and enantioselectivities. The diastereoselectivities (trans:cis) and enantiomeric excesses of the trans-oxazolines for the reaction with 1 mol % of the catalyst are as follows: R = Ph, 97:3, 96% ee; R = Me, 95:5, 97% ee; R = i-Pr, 98:2, 97% ee; R = (E)-MeCH=CH, 97:3; 99% ee; (E)-BnOCH(2)CH=CH, 96:4, 95% ee. These optically active oxazolines were converted to N,O-protected beta-hydroxy-alpha-amino aldehydes and ketone in high yields. An N-protected alpha-amino aldehyde (R = Ph) lacking the beta-hydroxyl group was also obtained through the catalytic hydrogenolysis of the oxazoline.
    DOI:
    10.1021/jo00111a034
  • 作为产物:
    参考文献:
    名称:
    Gold(I)-Catalyzed Asymmetric Aldol Reaction of N-Methoxy-N-methyl-.alpha.-isocyanoacetamide (.alpha.-Isocyano Weinreb Amide). An Efficient Synthesis of Optically Active .beta.-Hydroxy .alpha.-Amino Aldehydes and Ketones
    摘要:
    Asymmetric aldol reaction of N-methoxy-N-methyl-alpha-isocyanoacetamide (alpha-isocyano Weinreb amide) with aldehydes [RCHO: R = Ph, Me, i-Pr, (E)-MeCH=CH, (E)-BnOCH(2)CH=CH] in the presence of a gold(I) catalyst prepared in situ from [Au(c-HexNC)(2)]BF4 and chiral ferrocenylphosphine ligand (R)-N-methyl-N-(2-morpholinoethyl)-1-[(S)-1',2-bis(diphenylphosphino)ferrocenyl]ethylamine gave high yields of optically active trans-5-alkyl-2-oxazoline-4-(N-methoxy-N-methylcarboxamides) with high diastereo- and enantioselectivities. The diastereoselectivities (trans:cis) and enantiomeric excesses of the trans-oxazolines for the reaction with 1 mol % of the catalyst are as follows: R = Ph, 97:3, 96% ee; R = Me, 95:5, 97% ee; R = i-Pr, 98:2, 97% ee; R = (E)-MeCH=CH, 97:3; 99% ee; (E)-BnOCH(2)CH=CH, 96:4, 95% ee. These optically active oxazolines were converted to N,O-protected beta-hydroxy-alpha-amino aldehydes and ketone in high yields. An N-protected alpha-amino aldehyde (R = Ph) lacking the beta-hydroxyl group was also obtained through the catalytic hydrogenolysis of the oxazoline.
    DOI:
    10.1021/jo00111a034
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫